Atlas Trials

Ivermectin for Post Exposure Prophylaxis of Covid-19

Clinical trial NCT05231603 · TERMINATED

Trial details

NCT number
NCT05231603
Sponsor
Clinical Research Centre, Malaysia
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2022-02-16
Primary completion
2022-05-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.